| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2016 | GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers. | Ko, HW; Lee, HH; Huo, L; Xia, W; Yang, CC; Hsu, JL; Li, LY; Lai, CC; Chan, LC; Cheng, CC; Labaff, AM; Liao, HW; Lim, SO; Li, CW ; Wei, Y; Nie, L; Yamaguchi, H; Hung, MC | Oncotarget 7(35), 57131-57144 | |||
| 2015 | Selective expression of constitutively active pro-apoptotic protein BikDD gene in primary mammary tumors inhibits tumor growth and reduces tumor initiating cells. | Rahal, OM; Nie, L; Chan, LC; Li, CW ; Hsu, YH; Hsu, J; Yu, D; Hung, MC | American journal of cancer research 5(12), 3624-3634 | |||
| 2019 | Synergism of PARP inhibitor fluzoparib (HS10160) and MET inhibitor HS10241 in breast and ovarian cancer cells. | Han, Y; Chen, MK; Wang, HL; Hsu, JL; Li, CW ; Chu, YY; Liu, CX; Nie, L; Chan, LC; Yam, C; Wang, SC; He, GJ; Hortobagyi, GN; Tan, XD; Hung, MC | American journal of cancer research 9(3), 608-618 |
